People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adela, Inc. | — | Biotechnology | Series C | $108.5M | $156.3M | 2021 |
| Genome Medical Holding Co | — | Healthtech | Series C | $90.0M | $606.2M | 2018 |
Lisa Alderson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lisa Alderson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen Bloch | 1 | 15 |
| Paul Brown | 1 | 12 |
| Robert Weisskoff | 1 | 12 |
| Robert Green | 1 | 8 |
| Andrew ElBardissi | 1 | 7 |
| David Bonita | 1 | 6 |
| David Scheer | 1 | 6 |
| Jessica Zeaske | 1 | 5 |
| Nicholas Naclerio | 1 | 5 |
| Russell Glass | 1 | 5 |
| Randal Scott | 1 | 4 |
| Mark Sylvester | 1 | 3 |
| Shaun Rodriguez | 1 | 3 |
| Iana Dimkova | 1 | 2 |
| Tim Howe | 1 | 2 |
| Minh Merchant | 1 | 2 |
| Robert C Green | 1 | 2 |
| Maneesh Jain | 1 | 2 |
| Jill Davies | 1 | 2 |
| Alex Parker | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.